KEQU

KEWAUNEE SCIENTIFIC CORP /DE/

Information Technology Quarter ended 2026-04-30 Filed 2026-06-26

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) files with the SEC as an information technology company. Its most recent balance sheet puts total assets at $178M, against $101M of liabilities and $77M of equity, as at 2026-04-30. That balance sheet grew 1.3% against 2026-01-31, when total assets were $176M. Liabilities account for 56.9% of the balance sheet and equity 43.1%, about $1.32 of liabilities for every dollar of equity. The largest single line on the asset side is Receivables at $59M, 32.9% of total assets, followed by Inventory at $31M. Its largest single liability is Accounts payable at $22M, 12.6% of the balance sheet. By total assets it is the 573rd largest of the 979 information technology companies covered here. The figures come from a filing filed on 2026-06-26. Assets equal liabilities plus equity on the filed figures, so this balance sheet reconciles directly. Every figure above is as filed. Nothing is estimated, smoothed or restated, and where the filing and the identity disagree the disagreement is shown rather than closed.

What it owns, and who has a claim on it

Both columns are the same height because they are the same money, counted twice: once by what it is, once by who it belongs to.

Owns$178M
Owed & owned$101M + $77M
Assets, line by line
Cash$10M6%
Receivables$59M33%
Inventory$31M17%
Property & equipment$22M13%
Goodwill$12M7%
Intangibles$16M9%
Other assets$28M16%
Liabilities and equity, line by line
Accounts payable$22M13%
Other liabilitiesincludes 1 line item this filer does not report separately$79M44%
Shareholders' equity$77M43%

Not reported separately

This filer does not break these out. They are inside the totals, counted in the shaded remainder — not estimated, and not set to zero.

Long-term debt

Funding is split roughly evenly: equity is 43% of the balance sheet and liabilities 57%.

Not every line item is reported separately by this filer: long-term debt are inside the totals rather than broken out.

Where the money goes

Every dollar of revenue over the year ended 2026-04-30, and what is left after each cost comes out.

Revenue in$282M
Revenue and costs, line by line
Cost of salesWhat it costs to make or buy what it sells$202M71%
Operating costsRunning the business: staff, marketing, admin · computed as a remainder$64M23%
TaxTax on profit$3M1%
Everything elseInterest and other items · computed as a remainder$4M1%

Of every dollar KEQU took in, 0.03 was left as profit after all costs and tax — $10 million on $282 million of revenue.

The largest single outflow is cost of sales, at 71% of revenue.

The size of it

Its annual sales sit just below Fiji.

Maldives$7.2B
Barbados$6.8B
Fiji$5.7B
KEWAUNEE SCIENTIFIC CORP /DE/$282M
These measure different things. A country's GDP is everything it produced in a year. A company's revenue is what it sold. They share a unit, not a meaning — this shows how big the number is, and nothing more. A company is not "bigger than" a country.

Company figure: year ended 2026-04-30. GDP: World Bank, GDP (current US$), indicator NY.GDP.MKTP.CD, 2024.

Ask about these numbers

Answered from the figures on this page and nothing else. Ask for something that is not here — another company, a share price, an earlier quarter — and it will tell you it is not in the filing data.

This is a language model reading the same numbers you can see. It does not predict, rate or recommend.

Learn more

Every figure here is also available as JSON — the API reference and what it costs.

Related companies

The nearest in size that file in the same sector, each drawn to the same scale.